[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].

Ohmura T, Nishikawa H

Open source

DOI
10.1254/fpj.125.307
Published
2005 May
Container
Nihon yakurigaku zasshi. Folia pharmacologica Japonica
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1254/fpj.125.307,
  title = {[Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].},
  author = {Ohmura T and Nishikawa H},
  year = {2005},
  journal = {Nihon yakurigaku zasshi. Folia pharmacologica Japonica},
  doi = {10.1254/fpj.125.307},
  url = {https://doi.org/10.1254/fpj.125.307}
}

RIS

TY  - JOUR
TI  - [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].
AU  - Ohmura T
AU  - Nishikawa H
PY  - 2005
JO  - Nihon yakurigaku zasshi. Folia pharmacologica Japonica
DO  - 10.1254/fpj.125.307
UR  - https://doi.org/10.1254/fpj.125.307
ER  - 

APA

T, O., & H, N. (2005). [Pharmacological and clinical profile of tiotropium bromide (Spiriva), a new long-acting anticholinergic bronchodilator for COPD treatment].. Nihon yakurigaku zasshi. Folia pharmacologica Japonica. https://doi.org/10.1254/fpj.125.307

Source records